NDC 80425-0234-01 - Diclofenac Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0234
- Requested NDC
- 80425-0234-01
- Package NDCs from labels
- 80425-0234-1, 80425-0234-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Diclofenac Sodium - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0234-1 | Diclofenac Sodium | 1 in 1 CARTON | GEL | 1 | 3 | |
| 80425-0234-1 | Diclofenac Sodium | 100 g in 1 TUBE | GEL | 100 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0234 | DICLOFENAC SODIUM GEL [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 3 | Current NDC, Legacy NDC, 2 package rows | 20250102_f187ae44-71be-a682-e053-2995a90a6426.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0234-1 | GM - Gram | 80425-0234 | 4c04ffa9-1cdb-41ce-bc64-60c4b87fc621 | 1 | 2023-03-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diclofenac Sodium 1.5% | DICLOFENAC SODIUM TOPICAL | PHOENIX RX LLC | 3b40a448-3f5e-fe6f-e063-6394a90a32df | 2025-11-17 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| ARTHRITIS PAIN RELIEVER | DICLOFENAC SODIUM | H E B | 027803c5-85ae-4b86-8bd4-e61f8f34d036 | 2025-11-17 | Warnings | QTG126297Q |
| ARTHRITIS PAIN RELIEVING | DICLOFENAC SODIUM | Meijer, Inc. | 5cc570c6-2585-4d1a-9352-b1161458af9a | 2025-11-17 | Warnings | QTG126297Q |
| Diclofenac Sodium Delayed Release | DICLOFENAC SODIUM | PHOENIX RX LLC | 41472cca-278b-934b-e063-6294a90aaf5d | 2025-11-14 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | PHOENIX RX LLC | 4382cc15-8978-4f3b-e063-6394a90a9ecb | 2025-11-14 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium Topical 1% | DICLOFENAC SODIUM | YYBA CORP | 043df5d2-6f3e-311f-e063-6294a90a23d7 | 2025-11-10 | Warnings | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Advanced Rx of Tennessee, LLC | 0b4fd47f-903c-097b-e063-6394a90a49ab | 2025-11-10 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Lupin Pharmaceuticals, Inc. | 609c5344-9c97-4fa8-ad53-d0f622ce64ec | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM TOPICAL GEL, 1% | Dr. Reddy's Laboratories Inc. | c88b2512-0255-658d-252a-c006275159b0 | 2025-10-28 | Warnings | QTG126297Q |
| Arthritis Pain | DICLOFENAC SODIUM TOPICAL GEL, 1% | Strategic Sourcing Services, LLC | 5de514ee-fd59-ef95-8dc3-16e34321572b | 2025-10-28 | Warnings | QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM TOPICAL GEL, 1% | Chain Drug Marketing Association INC | 625d21e8-0731-1157-30fe-9f9868ff8dc4 | 2025-10-28 | Warnings | QTG126297Q |
| Diclofenac Sodium Topical Gel 1% | DICLOFENAC SODIUM TOPICAL GEL, 1% | Walgreens Company | 40d0553b-a97a-1315-3fca-8ef38611505e | 2025-10-28 | Warnings | QTG126297Q |
| Arthritis Pain | DICLOFENAC SODIUM TOPICAL GEL, 1% | Discount Drug Mart, Inc. | ae1ebe9c-b1fa-6762-949e-cb83b33319a2 | 2025-10-28 | Warnings | QTG126297Q |
| Diclofenac Sodium Topical Gel 1% | DICLOFENAC SODIUM TOPICAL GEL, 1% | Kroger Company | 2081371d-436a-16fc-db80-ced6288f52bc | 2025-10-28 | Warnings | QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM TOPICAL GEL, 1% | GERI-CARE PHARMACEUTICALS CORP | 91fc618a-edd0-5944-083f-c00075476f55 | 2025-10-28 | Warnings | QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | GLENMARK PHARMACEUTICALS INC., USA | dab3ae60-0135-43b3-a1d0-8752720af82a | 2025-10-27 | Boxed warning, Warnings, Adverse reactions | 855642 QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | PHOENIX RX LLC | 41da2e11-58c7-9622-e063-6394a90a9fdb | 2025-10-23 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC | PHOENIX RX LLC | 41dab520-5651-a4c5-e063-6394a90a2962 | 2025-10-23 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | BluePoint Laboratories | feb1541a-de83-47dd-be03-c43376527318 | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM TOPICAL GEL, 1% | Encube Ethicals, Inc. | 6e8c45e1-8cd4-4ff7-a758-f9d2ed37e593 | 2025-10-01 | Warnings | QTG126297Q |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.